A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
Two European partners will soon be vying for dominance in a new battleground: vaccines to protect travelers against a painful ...
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in ...
COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a ...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN ® smallpox vaccine to the strategic ...
Bavarian Nordic has an annual production capacity of 30 million doses. According to the drugmaker's Vice President Sass Sørensen, the vaccine is “in stock in numerous countries” and can be ...
COPENHAGEN, Denmark, April 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons ...
People wait in line for a monkeypox vaccine at one of the few Chicago locations distributing the shot on Monday, July 25, 2022. With vaccine in extremely short supply, this clinic can currently only ...
Cases of mpox, formerly known as monkeypox, are on the rise at the start of 2024, according to Centers for Disease Control ...
Ritchie Torres filed legislation this week aimed at improving the HHS' response to mpox and other health emergencies.
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a ...